Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Tang

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Leukemia|March 9, 2021
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
Leukemia|August 6, 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
The Lancet. Oncology|July 30, 2016
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association studyZheng Li, Yi Xia, Li-Na Feng, et al.
American Journal of Hematology|June 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohortJing Quan Lim, Dachuan Huang, Jason Yongsheng Chan, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Leukemia|March 9, 2021
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
Leukemia|August 6, 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphomaJing Quan Lim, Dachuan Huang, Tiffany Tang, et al.
The Lancet. Oncology|July 30, 2016
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association studyZheng Li, Yi Xia, Li-Na Feng, et al.
American Journal of Hematology|June 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohortJing Quan Lim, Dachuan Huang, Jason Yongsheng Chan, et al.
Pageof 10